{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T19:04:08Z","timestamp":1776452648253,"version":"3.51.2"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Polish National Science Centre","doi-asserted-by":"publisher","award":["6865\/B\/P01\/2011\/40"],"award-info":[{"award-number":["6865\/B\/P01\/2011\/40"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.transproceed.2018.04.036","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T22:37:55Z","timestamp":1524004675000},"page":"3789-3796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential Leukemic Cells Engraftment After Hematopoietic Stem Cell Transplantation From Unrelated Donors With Undiagnosed Chronic Leukemia"],"prefix":"10.1016","volume":"50","author":[{"given":"M.P.","family":"Kawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Litwi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gniot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pius-Sadowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rogi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Zdziarska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Machali\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.04.036_bib1","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.transproceed.2017.09.027","article-title":"Incidence of infectious complications in children with acute lymphoblastic leukemia treated with hematopoietic stem cell transplantation","volume":"49","author":"Zaucha-Prazmo","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.04.036_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1704588","article-title":"Transmission of donor illness by stem cell transplantation: should screening be different in older donors?","volume":"34","author":"Niederwieser","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2018.04.036_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.24275","article-title":"Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring","volume":"91","author":"Jabbour","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transproceed.2018.04.036_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4082\/kjfm.2015.36.5.197","article-title":"An overview and update of chronic myeloid leukemia for primary care physicians","volume":"36","author":"Granatowicz","year":"2015","journal-title":"Korean J Fam Med"},{"key":"10.1016\/j.transproceed.2018.04.036_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10561-007-9036-1","article-title":"Donor-derived malignancy following transplantation: a review","volume":"8","author":"Gandhi","year":"2007","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.transproceed.2018.04.036_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0609.2009.01357.x","article-title":"BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients","volume":"84","author":"Le Coutre","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.transproceed.2018.04.036_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.leukres.2004.07.008","article-title":"Chronic myeloid leukemia following kidney transplantation","volume":"29","author":"Pelloso","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.transproceed.2018.04.036_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1399-0012.2007.00775.x","article-title":"Atypical chronic myeloid leukemia following organ transplants","volume":"22","author":"Fontana","year":"2007","journal-title":"Clin Transpl"},{"key":"10.1016\/j.transproceed.2018.04.036_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3727\/096368915X688560","article-title":"Hematopoietic cell and renal transplantation in plasma cell dyscrasia patients","volume":"25","author":"Baraldi","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.transproceed.2018.04.036_bib10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.transproceed.2017.04.006","article-title":"An unusual case of acute myeloid leukemia cell infiltration of the renal allograft: a case report and review of literature","volume":"49","author":"Manohar","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.04.036_bib11","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3109\/10428191003802340","article-title":"Human leukocyte antigen class I alleles and the risk of chronic myelogenous leukemia: a meta-analysis","volume":"51","author":"Naugler","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transproceed.2018.04.036_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1586\/ehm.10.32","article-title":"Relapse after allogeneic stem cell transplantation","volume":"3","author":"Barrett","year":"2010","journal-title":"Exp Rev Hematol"},{"key":"10.1016\/j.transproceed.2018.04.036_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3727\/096368912X661319","article-title":"Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study","volume":"23","author":"Liu","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.transproceed.2018.04.036_bib14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbmt.2010.10.010","article-title":"Donor cell leukemia: a review","volume":"17","author":"Wiseman","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2018.04.036_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(71)90998-6","article-title":"Leukaemic transformation of engrafted marrow cells in\u00a0vivo","volume":"297","author":"Fialkow","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2018.04.036_bib16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0145-2126(82)90067-4","article-title":"The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation","volume":"6","author":"Boyd","year":"1982","journal-title":"Leuk Res"},{"key":"10.1016\/j.transproceed.2018.04.036_bib17","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2006-07-021980","article-title":"Donor cell leukemia: insight into cancer stem cells and the stem cell niche","volume":"109","author":"Flynn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2018.04.036_bib18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200308283490921","article-title":"Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation","volume":"349","author":"Baron","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2018.04.036_bib19","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/bmt.2014.294","article-title":"Inadvertent transmission of occult CML through allo-SCT","volume":"50","author":"de Brito","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2018.04.036_bib20","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.4238\/2013.October.24.8","article-title":"Analysis of BCR\/ABL transcripts in healthy individuals","volume":"12","author":"Boquett","year":"2013","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.transproceed.2018.04.036_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/0019-5049.144647","article-title":"Overview of blood components and their preparation","volume":"58","author":"Basu","year":"2014","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.transproceed.2018.04.036_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/bies.201100169","article-title":"Extracellular vesicles\u2014vehicles that spread cancer genes","volume":"34","author":"Rak","year":"2012","journal-title":"Bioessays"},{"key":"10.1016\/j.transproceed.2018.04.036_bib23","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.transproceed.2016.05.016","article-title":"Morphologic changes in the dermis after the single administration of autologous fibroblastic cells: a preliminary study","volume":"48","author":"Machalinski","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.04.036_bib24","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0041-1345(99)00275-4","article-title":"Isolation of hematopoietic stem cells from heparinized cadaveric multiple organ donors: potential clinical implications","volume":"31","author":"Marlicz","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.04.036_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/TP.0b013e31823e7ae2","article-title":"Bone marrow of multiorgan donors underutilized","volume":"93","author":"Baumert","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.04.036_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.12659\/AOT.881996","article-title":"Aldehyde dehydrogenase (ALDH)\u2014a promising new candidate for use in preclinical and clinical selection of pluripotent very small embryonic-like stem cells (VSEL SCs) of high long-term repopulating hematopoietic potential","volume":"16","author":"Paczkowska","year":"2011","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2018.04.036_bib27","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","article-title":"Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease","volume":"13","author":"van Dongen JJM","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.transproceed.2018.04.036_bib28","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.transproceed.2016.07.028","article-title":"Identification of suitable reference genes for mRNA studies in bone marrow in a mouse model of hematopoietic stem cell transplantation","volume":"48","author":"Li","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.04.036_bib29","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.leukres.2011.03.022","article-title":"Effect of the duration and quality of peripheral blood sample storage on the results of qualitative and quantitative BCR-ABL transcript analyses in patients with CML","volume":"35","author":"Moravcova","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.transproceed.2018.04.036_bib30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1600-6135.2005.00838.x","article-title":"Quantifying organ donation rates by donation service area","volume":"5","author":"Ojo","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.04.036_bib31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bjh.12885","article-title":"Elevated incidence of chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients","volume":"166","author":"Dhanarajan","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2018.04.036_bib32","first-page":"53","article-title":"Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods","volume":"44","author":"Gajkowska","year":"2006","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.transproceed.2018.04.036_bib33","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2018.04.036_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1634\/stemcells.20-3-259","article-title":"Immature leukemic CD34+CXCR4+cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1","volume":"20","author":"Peled","year":"2002","journal-title":"Stem Cells"},{"key":"10.1016\/j.transproceed.2018.04.036_bib35","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3727\/096368915X689424","article-title":"Dimethyl sulfoxide (DMSO) increases percentage of CXCR4+ hematopoietic stem\/progenitor cells, their responsiveness to an SDF-1 gradient, homing capacities, and survival","volume":"25","author":"Jarocha","year":"2016","journal-title":"Cell Transplant"},{"key":"10.1016\/j.transproceed.2018.04.036_bib36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","article-title":"Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia","volume":"21","author":"Zhang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.transproceed.2018.04.036_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Epstein","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2018.04.036_bib38","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/00007890-200104150-00031","article-title":"Heparinized cadaveric organ donors (HCOD)\u2014a potential source of hematopoietic cells for transplantation and gene therapy","volume":"71","author":"Machalinski","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.04.036_bib39","first-page":"1","article-title":"Biodistribution, uptake and effects caused by cancer-derived extracellular vesicles","volume":"4","author":"Sadovska","year":"2015","journal-title":"J\u00a0Circ Biomark"},{"key":"10.1016\/j.transproceed.2018.04.036_bib40","doi-asserted-by":"crossref","first-page":"e105200","DOI":"10.1371\/journal.pone.0105200","article-title":"Transferred BCR\/ABL DNA from K562 extracellular vesicles causes chronic myeloid leukemia in immunodeficient mice","volume":"9","author":"Cai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2018.04.036_bib41","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3324\/haematol.2009.009134","article-title":"Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript","volume":"94","author":"Lucas","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.transproceed.2018.04.036_bib42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-2141.1998.01033.x","article-title":"Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia","volume":"103","author":"Lichty","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2018.04.036_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/939706","article-title":"Detection of BCR-ABL positive cells in an asymptomatic patient: a case report and literature review","volume":"2010","author":"Bayraktar","year":"2010","journal-title":"Case Rep Med"},{"key":"10.1016\/j.transproceed.2018.04.036_bib44","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3892\/mmr.2014.1951","article-title":"Incidence of bcr-abl fusion transcripts in healthy individuals","volume":"9","author":"Ismail","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.transproceed.2018.04.036_bib45","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/bmt.2015.199","article-title":"Transmission of CML or of t(9; 22) and BCR\/ABL? They are not the same","volume":"50","author":"Gale","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2018.04.036_bib46","first-page":"421","article-title":"Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation","volume":"58","author":"Deininger","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.transproceed.2018.04.036_bib47","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1182\/blood.V98.10.2887","article-title":"Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein","volume":"98","author":"Clark","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2018.04.036_bib48","first-page":"969","article-title":"Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"90","author":"Hertenstein","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.transproceed.2018.04.036_bib49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ajh.20389","article-title":"Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature","volume":"81","author":"Reichard","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transproceed.2018.04.036_bib50","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ejmp.2016.10.019","article-title":"NOD-SCID mice irradiation with medical accelerators: dosimetric and radiobiological results","volume":"32","author":"Miranti","year":"2016","journal-title":"Phys Med"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518306067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518306067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T23:18:41Z","timestamp":1571181521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518306067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0041134518306067"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.04.036","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential Leukemic Cells Engraftment After Hematopoietic Stem Cell Transplantation From Unrelated Donors With Undiagnosed Chronic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}